OBGYN.net, an online community for medical professionals
In this blog, Deborah Ottenheimer, MD, discusses her move from a hospital staff physician to a solo private practice, a decision that hasn't come without costs. Can you relate?
With this new FDA guidance, the group of women for whom laparoscopic power morcellation remains an appropriate treatment option is quite narrowed.
Being overweight can affect fertility, and now there is evidence that maternal weight at conception impacts how a fertilized egg divides and grows.
New technology—inspiring jealousy and one-upmanship everywhere. (Who said pregnant women weren't competitive?)
The inflow Intraurethral Valve-Pump, a device intended for use in women with impaired detrusor contractility (IDC), has been given FDA marketing approval.
What does a cholesterol medication have to do with uterine fibroid tumors? New animal research explains one drug's effect on uterine leiomyoma cells.
Ever wonder about investing in 3D technology, the best candidates for LESS, and the utility of dual-function instruments? Here's one OB/GYN's opinion.
How much does ospemifene really help in the improvement of sexual function in postmenopausal women? David Portman, MD, discusses new study findings.
Maestro AR, an advanced, procedure-specific training software, gives users of the da Vinci robotic surgical system instant feedback in a 3D environment.
This surgical video shows resection of a 3-cm intracavity fibroid using minimally invasive surgical technology. The patient, a 40-year-old woman, presented with a 60-day history of abnormal bleeding.
This video demonstrates a case in which an intrauterine device (IUD) IUD was trapped--not in the uterine cavity and not outside the uterine wall, but within the muscle of the uterus. It was extracted under laparoscopic guidance.
Actress Kim Cattrall discusses her menopause journey and partnership with Tune In To Menopause, an awareness campaign designed to empower women.
Research suggests that prophylactic 17P can be useful in reducing the risk of spontaneous preterm delivery (SPTD), and one large study showed how compliance, and therefore results, can be improved.
Your patient just received devastating news: she has cancer. As treatment options and anxieties swirl, more and more women are now faced with another issue: how will the cancer and its treatment impact their fertility?
Lead researcher Dr Janet McLaren discusses the results of a new study exploring new concerns that rheumatoid arthritis, lupus, and inflammatory bowel disease may lead to premature ovarian failure and early menopause.